nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Ipratropium bromide—Oedema—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Ipratropium bromide—Nausea—Pentoxifylline—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Ipratropium bromide—Infection—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mometasone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Ipratropium bromide—Hypotension—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Ipratropium bromide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Ipratropium bromide—Palpitations—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Ipratropium bromide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Ipratropium bromide—Cough—Lisinopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Ipratropium bromide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Ipratropium bromide—Tension—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Ipratropium bromide—Insomnia—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Ipratropium bromide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Ipratropium bromide—Paraesthesia—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Chest pain—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Myalgia—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Dyspnoea—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Ipratropium bromide—Dyspepsia—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Ipratropium bromide—Vomiting—Mometasone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Ipratropium bromide—Dry mouth—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Ipratropium bromide—Rash—Mometasone—systemic scleroderma	0.001	0.001	CcSEcCtD
Ipratropium bromide—Asthenia—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Ipratropium bromide—Dermatitis—Mometasone—systemic scleroderma	0.001	0.001	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.001	0.001	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Ipratropium bromide—Headache—Mometasone—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Ipratropium bromide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Ipratropium bromide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Ipratropium bromide—Fatigue—Leflunomide—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Ipratropium bromide—Oedema—Lisinopril—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Ipratropium bromide—Pruritus—Captopril—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Ipratropium bromide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Ipratropium bromide—Constipation—Leflunomide—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Ipratropium bromide—Pain—Leflunomide—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Ipratropium bromide—Infection—Lisinopril—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Ipratropium bromide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Ipratropium bromide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Ipratropium bromide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Ipratropium bromide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Ipratropium bromide—Tachycardia—Lisinopril—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Ipratropium bromide—Abdominal pain—Azathioprine—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Ipratropium bromide—Skin disorder—Lisinopril—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Ipratropium bromide—Diarrhoea—Captopril—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Ipratropium bromide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Ipratropium bromide—Nausea—Mometasone—systemic scleroderma	0.000945	0.000945	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Ipratropium bromide—Pain—Mycophenolic acid—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Ipratropium bromide—Constipation—Mycophenolic acid—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Ipratropium bromide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Ipratropium bromide—Cough—Mycophenolate mofetil—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Ipratropium bromide—Hypotension—Lisinopril—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Ipratropium bromide—Dizziness—Captopril—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Ipratropium bromide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000917	0.000917	CcSEcCtD
Ipratropium bromide—Urticaria—Leflunomide—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Ipratropium bromide—Abdominal pain—Leflunomide—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Ipratropium bromide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000904	0.000904	CcSEcCtD
Ipratropium bromide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000904	0.000904	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Ipratropium bromide—Insomnia—Lisinopril—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Ipratropium bromide—Paraesthesia—Lisinopril—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Ipratropium bromide—Vomiting—Captopril—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Ipratropium bromide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Ipratropium bromide—Dyspnoea—Lisinopril—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Ipratropium bromide—Rash—Captopril—systemic scleroderma	0.000881	0.000881	CcSEcCtD
Ipratropium bromide—Dermatitis—Captopril—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Ipratropium bromide—Somnolence—Lisinopril—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Ipratropium bromide—Headache—Captopril—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Ipratropium bromide—Dyspepsia—Lisinopril—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Ipratropium bromide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Ipratropium bromide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Ipratropium bromide—Infection—Mycophenolate mofetil—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Ipratropium bromide—Fatigue—Lisinopril—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Ipratropium bromide—Pain—Lisinopril—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Ipratropium bromide—Constipation—Lisinopril—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Ipratropium bromide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Ipratropium bromide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Ipratropium bromide—Diarrhoea—Azathioprine—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Ipratropium bromide—Nausea—Captopril—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Ipratropium bromide—Asthenia—Leflunomide—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Ipratropium bromide—Pruritus—Leflunomide—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Ipratropium bromide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—systemic scleroderma	0.000807	0.000807	CcSEcCtD
Ipratropium bromide—Dizziness—Azathioprine—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Ipratropium bromide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Ipratropium bromide—Diarrhoea—Leflunomide—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Ipratropium bromide—Urticaria—Lisinopril—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Ipratropium bromide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lisinopril—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Ipratropium bromide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Ipratropium bromide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Ipratropium bromide—Vomiting—Azathioprine—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Ipratropium bromide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Ipratropium bromide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00077	0.00077	CcSEcCtD
Ipratropium bromide—Rash—Azathioprine—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Ipratropium bromide—Dermatitis—Azathioprine—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Ipratropium bromide—Headache—Azathioprine—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Ipratropium bromide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Ipratropium bromide—Dizziness—Leflunomide—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Ipratropium bromide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Ipratropium bromide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Ipratropium bromide—Vomiting—Leflunomide—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Ipratropium bromide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Ipratropium bromide—Rash—Leflunomide—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Ipratropium bromide—Dermatitis—Leflunomide—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Ipratropium bromide—Nausea—Azathioprine—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Ipratropium bromide—Headache—Leflunomide—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Ipratropium bromide—Asthenia—Lisinopril—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Ipratropium bromide—Pruritus—Lisinopril—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Ipratropium bromide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Ipratropium bromide—Rash—Mycophenolic acid—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Ipratropium bromide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—systemic scleroderma	0.000691	0.000691	CcSEcCtD
Ipratropium bromide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Ipratropium bromide—Headache—Mycophenolic acid—systemic scleroderma	0.000688	0.000688	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Ipratropium bromide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Ipratropium bromide—Nausea—Leflunomide—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lisinopril—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Ipratropium bromide—Dizziness—Lisinopril—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Ipratropium bromide—Nausea—Mycophenolic acid—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Ipratropium bromide—Vomiting—Lisinopril—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Ipratropium bromide—Rash—Lisinopril—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Ipratropium bromide—Dermatitis—Lisinopril—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Ipratropium bromide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Ipratropium bromide—Headache—Lisinopril—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Ipratropium bromide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Ipratropium bromide—Nausea—Lisinopril—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Ipratropium bromide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Ipratropium bromide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000551	0.000551	CcSEcCtD
Ipratropium bromide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Ipratropium bromide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Ipratropium bromide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Ipratropium bromide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000515	0.000515	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Ipratropium bromide—Vomiting—Prednisone—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Ipratropium bromide—Rash—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Ipratropium bromide—Headache—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Ipratropium bromide—Nausea—Prednisone—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
